DalsnaFinance

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

Markets GlobeNewswire By GlobeNewswire 09 Jun 2026 16:47 1 min read
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

PRESS RELEASE

PRESS RELEASE

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.